Stay updated with breaking news from Nasdaq Rlay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued a report on […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has received a consensus recommendation of “Buy” from the six brokerages that are presently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have covered the stock in the last year […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) CFO Thomas Catinazzo sold 1,695 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $6.38, for a total transaction of $10,814.10. Following the transaction, the chief financial officer now directly owns 339,803 shares […]
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $5.74 and last traded at $5.79, with a volume of 59899 shares. The stock had previously closed at $5.90. Wall Street Analysts Forecast Growth A number of equities analysts […]
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to […]